Results

Total Results: 1,134 records

Showing results for "days".

1. Rapid Evidence Product: Adverse Events Associated With COVID-19 Pharmaceutical Treatments (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/COVID-19-pharmaceutical-treatments-rapid-review.pdf
   March 01, 2024 - Serious adverse events, convalescent plasma, 45 days or less Serious Adverse Event Study ID Days … Serious adverse events, convalescent plasma, more than 45 days Serious Adverse Event Study ID Days … Timing ranged from 7 to 29 days. … Serious adverse events, more than 45 days, sotrovimab Serious Adverse Event Study ID Days n/N … Serious adverse events, tocilizumab, more than 45 days Serious Adverse Event Study ID Days n/N

2. App-E-Surv-Report-3-Acute-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-acute-pain.xlsx
   May 29, 2025 - 1 day, 4 days, and 7 days 1 day to 1 week A vs. … 1 day, 2 days, 3 days, 4 days, 5 days 1 day to 1 week A vs. … Three times per day for four days 1 day to 1 week A vs. … Daily for 14 days 1 day to 1 1 week to 1 month A vs. … B: 45 60 56% NR Excluded NR NR NR Excluded Postoperative Worst: 5.2 (2.1) 7 days Daily for 7 days 1

3. App-E-Surv-Report-2-Acute-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-acute-pain.xlsx
   May 29, 2025 - 1 day, 4 days, and 7 days 1 day to 1 week A vs. … 1 day, 2 days, 3 days, 4 days, 5 days 1 day to 1 week A vs. … Three times per day for four days 1 day to 1 week A vs. … Daily for 14 days 1 day to 1 1 week to 1 month A vs. … B: 45 60 56% NR Excluded NR NR NR Excluded Postoperative Worst: 5.2 (2.1) 7 days Daily for 7 days 1

4. CER 225: Evidence Summary Interventions for Substance Use Disorders in Adolescents: A Systematic Review (pdf file)
   effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-evidence-summary%20225%20Substance%20Use%20Adolescents.pdf
   May 01, 2020 - behavioral interventions (that involve 1 or 2 encounters only)  Motivational interviewing decreases days … ) to reduce days of opioid use and achieve abstinence … by up to 0.7 days per month, alcohol use days by up to 1.2 days per month and overall substance use … by 3.5 days per month compared to treatment as usual. … None of the intensive interventions were found to reduce cannabis use days.

5. Appendix C: Fiber Intake and Laxation in People With Normal Bowel Function Report (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-prepub-final-research-appendix-c.xlsx
   January 01, 2024 - antibiotic use (within 3 wk), extreme dietary habits, alcohol abuse, and pregnancy. 4 wk 3 wk 28/28 d Days … antibiotic use (within 3 wk), extreme dietary habits, alcohol abuse, and pregnancy. 4 wk 3 wk 28/28 d Days … serum cholesterol concentrations >260 mg/dl with no evidence of secondary causes NR 3 wk NR 21/21 d Days … 1-21 Behall 1987 3039826 US RCT cross-over < 1987 NR NR Community NR NR 4 wk NA 8/28 d Days 21-28 … NR 18 d 10 d 10/18 d days 9-18 Lampe 1992 1339081 U.S.

6. Fiber-Intake-Final-Appendix-C (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/fiber-intake-final-appendix-c.xlsx
   January 01, 2024 - antibiotic use (within 3 wk), extreme dietary habits, alcohol abuse, and pregnancy. 4 wk 3 wk 28/28 d Days … antibiotic use (within 3 wk), extreme dietary habits, alcohol abuse, and pregnancy. 4 wk 3 wk 28/28 d Days … serum cholesterol concentrations >260 mg/dl with no evidence of secondary causes NR 3 wk NR 21/21 d Days … 14-24 Behall 1987 3039826 US RCT cross-over < 1987 NR NR Community NR NR 4 wk NA 8/28 d Days 21-28 … NR 18 d 10 d 10/18 d days 9-18 Lampe 1992 1339081 U.S.

7. App-E-Surv-Rept-1-Acute-Pain (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-rept-1-acute-pain.xlsx
   May 29, 2025 - B: Topical capsaicin (0.5%; cream) 3 times per day for 3 days NA 160 A: 80 B: 80 119 A: 60 B: 59 43 … 1 day, 4 days, and 7 days 1 day to 1 week A vs. … Days 1, 2, 3, 4, 5, 6, 7; 2 and 6 weeks 2 weeks to <4 weeks ≥4 weeks A vs. … Three times per day for four days 1 day to 1 week A vs. … B: 45 60 56% NR Excluded NR NR NR Excluded Postoperative Worst: 5.2 (2.1) 7 days Daily for 7 days 1

8. Engaging-Caregivers-Appendix-B (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-appendix-b.xlsx
   May 29, 2025 - ), 1 long-term facility (mean stay 30 to 45 days) Adolescent Inclusion: Caregiver: 1) Legal guardian … drank alcohol; Days used cannabis; Days used any substance; Substance-related problems; Caregiver satisfaction … B Proportion days drank alcohol (Time x Condition) RR 0.89 (95% CI 0.65 to 1.23) Proportion days used … Duration: ~30 minutes Followup: 30 days NR Readmissions A vs. … Duration: 3 days Followup: 1 year NR Readmissions A vs.

9. Version-3-Immunity-After-Covid-19-Appendix-Table-B-1 (xls file)
   effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19-appendix-table-B-1.xlsx
   January 24, 2022 - : 30 (85.7) Hospitalized >5 days: 4 (11.4) ICU: 1 (2.9) Immunocompetent: Hospitalized <5 days: 11 ( … Every 15 days until end of study period Asymptomatic Total: 18* (8.9)* HIV-: 12 (6.5) HIV+: 6 (33.3) … (3.5 months) Unvaccinated: 164 days (5.5 days) Delta (99.93% of all infections during the Delta predominance … Negative cohort: 358,346 tests performed on average every 14.8 days. … Positive cohort: 131,896 tests performed on average every 14.3 days. 90 days (unvaccinated participants

10. Standardized Library of Asthma Outcome Measures (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-library-asthma.pdf
    April 01, 2019 - assert that the missed days are due to asthma (as opposed to another condition). … /missed work days Missed school days: Patient has had one or more missed school days due to asthma … in the past 12 months, or Number of days missed from school (preferably days missed due to asthma … Missed work days: Caregiver has had one or more missed days of work due to child's asthma in the past … 12 months, or patient has missed one or more days of work due to his/her own asthma.

11. Pharmacotherapy for Adults with Alcohol-Use Disorders in Outpatient Settings (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy-surveillance.pdf
    September 01, 2017 - drinks per drinking days. … No significant difference was found for drinking days (3 studies) and heavy drinking days (3 studies … , and number of heavy drinking days … days with use of acamprosate. … Smokers Smokers who received natrexone had more days without drinking, and more days without heavy

12. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D2 Tables (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d2.xlsx
    January 01, 2024 - The radiotherapy planning CT scan took place at least 7 days after fiducial placement. … , and oral tamsulosin (0.4 mg/d) for 30 days after treatment. … , and oral tamsulosin (0.4 mg/d) for 30 days after treatment. … Treatment with RT commenced within 30 days after fiducial marker/spacer placement. … Treatment with RT commenced within 30 days after fiducial marker/spacer placement.

13. Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-summary.pdf
    November 01, 2023 - and in heavy drinking days, resulting in low strength of evidence … , and percent heavy drinking days at the 50 mg oral dose. … and in heavy drinking days, resulting in low strength of evidence. … days and drinks per drinking day. … days.

14. Patient-Monitoring-Systems-Appendix-C (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-appendix-c.xlsx
    January 01, 2024 - : 9.4 (SD 14) NR Reference None Chin, 2020 Arm 2 Intervention, daily BPAs Hospital length of stay, days … ) NR Reference None Heller, 2020 Arm 2 Post-intervention (Autmoated MEWS) Hospital length of stay, days … (SD 3.4) NR Reference None Balshi, 2022 Arm 2 Post-intervention (Wireless) Average length of stay, days … <0.001 None Eddachouri, 2023 Arm 1 -Usual care/In person Pre-intervention Hospital length of stay, days … Rowland, 2024 Arm 1 -Usual care/In person Standard intermittent monitoring Hospital length of stay, days

15. Angina-Heart-Attack-Treatments Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
    January 01, 2014 - lower rates of revascularization (high SOE) but with a higher risk of major bleeding events at 30 days … Heparin-Based Strategy With Planned GPI Use (continued) Nonfatal MI at 30 days SOE = Moderate (3 RCTs … Heparin-Based Strategy Composite of all-cause mortality, nonfatal MI, or revascularization at 30 days … SOE = Low (4 RCTs; 11,858 patients) OR 0.97 (0.80 to 1.18); no difference Major bleeding at 30 days … Major bleeding at 30 days SOE = Insufficient (3 observational studies; 7,498 patients) Insufficient

16. Appendix-Table-B-1-Observational-Studies (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendix-table-B-1-observational-studies.xlsx
    March 20, 2021 - Elecsys Anti-SARS-CoV-2 assay Individuals in the positive cohort who had at least one PCR+ swab ≥14 days … ELISA In-house IgG RBD ELISA (82.4% sensitivity and 99.6 specificity) Defined as a new PCR+ test >30 days … December 20, 2020, to March 20, 2021, 4,606,247 PCR tests were performed (8,040 per million person-days … assays" NR Possible reinfection defined as a positive cohort participant with two PCR+ samples ≥90 days … after primary PCR+ test PCR Tests per 10,000 days at risk Positive: 8.0 Negative: 8.7 Asymptomatic

17. App-D-Opioid-Chronic-Pain-Surveill-Report-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveill-report-1.xlsx
    September 30, 2015 - States Duration: 12 month followup Inclusion: Patients with chronic opioid therapy (≥84 consecutive days … ; <2 NRS pain scores 180 days prior to index date (with ≥1 within 90 days prior to index date); <2 NRS … pain scores in followup period; death <180 days from index date. … in mean MED: 77.29% vs. 1.13% Mean NRS (95% CI), 90 days before index date: 4.64 (4.61 to 4.68) vs. … B (propensity matched) Mean pain scores (95% CI) First 90 days post-index: 4.68 (4.64 to 4.72) vs. 4.32

18. PHARMACO-EPIDEMIOLOGIC METHODS FOR A STUDY OF (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotic-medicine-cardiovascular-elderly_research.pdf
    February 01, 2009 - (adjusted HR 1.10; 95% CI 1.02-1.19) and 120 days (adjusted HR 1.09; 95% CI 1.02-1.16). … In the first 180 days of use, 17.9% of patients who began conventional APMs died, compared to 14.6% … of Events within 60 days Counts of Events within 120 days Count (%) Count (%) Count (% … HR (95%CI) in 60 days HR (95%CI) in 120 days Acute myocardial Infarction 0.93 (0.66 … HR* (95%CI) in 60 days Adjusted HR* (95%CI) in 120 days Acute myocardial infarction

19. Disposition of Comments_Comparative Effectiveness Review No. 262_Pharmacotherapy for Adults With Alcohol Use Disorder in Outpatient Settings: Systematic Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-262-pharmacotherapy-alcohol-disposition-comments.pdf
    November 07, 2023 - , heavy drinking days, and drinks per drinking day. … Number of episodes or days doesn't seem equivalent to me as days with no drinking. … Public Comment #3 (APA) Results p. 25 Drinking days Need to state number of drinking days over what … Similarly for the number of heavy drinking days. … If it's percent of drinking days, it would be better to say that.

20. App-D-Opioid-Chronic-Pain-Surveillance-Report-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-opioid-chronic-pain-surveillance-report-2.xlsx
    September 30, 2015 - States Duration: 12 month followup Inclusion: Patients with chronic opioid therapy (≥84 consecutive days … ; <2 NRS pain scores 180 days prior to index date (with ≥1 within 90 days prior to index date); <2 NRS … pain scores in followup period; death <180 days from index date. … in mean MED: 77.29% vs. 1.13% Mean NRS (95% CI), 90 days before index date: 4.64 (4.61 to 4.68) vs. … B (propensity matched) Mean pain scores (95% CI) First 90 days post-index: 4.68 (4.64 to 4.72) vs. 4.32